CYTOKINETICS, INCORPORATED Contract Liability (Deferred Revenue)
CYTOKINETICS, INCORPORATED (CYTK) had Contract Liability (Deferred Revenue) of $8.13 million as of 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2018-08-07
- 2018-06-30: Contract with Customer, Liability, Current $8.13M.
- 2018-03-31: Contract with Customer, Liability, Current $15.84M.
- 2017-12-31: Contract with Customer, Liability, Current $0.00.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2018-06-30 | $8.13M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $15.84M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |